{"id":10211,"date":"2025-12-31T15:22:41","date_gmt":"2025-12-31T07:22:41","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=10211"},"modified":"2026-01-30T17:58:50","modified_gmt":"2026-01-30T09:58:50","slug":"announce-the-record-date-of-2025-cash-capital-increase-and-share-subscription-schedule-issue-price","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/announce-the-record-date-of-2025-cash-capital-increase-and-share-subscription-schedule-issue-price\/","title":{"rendered":"Announce the record date of 2025 cash capital increase and share subscription schedule (Issue Price)"},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2025\/12\/31<\/td>\nTime of announcement<\/td>\n15:22:21<\/td>\n<\/tr>\n
Subject<\/td>\n\n
Announce the record date of 2025 cash capital\r\nincrease and share subscription schedule (Issue Price)<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2025\/12\/31<\/td>\nTo which item it meets<\/td>\nparagraph 11<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the board of directors resolution or\r\ndecision by the Company for record date:2025\/12\/22\r\n2.Whether to adopt shelf registration (Yes, please state issuance period \/No):\r\nNo\r\n3.Effective registration date approved by competent authority:2025\/12\/22\r\n4.Date of the board of directors resolution for (additional) issuance\r\nof shares:Not Applicable.\r\n5.Total monetary value of the issuance and number of shares issued:\r\nTotal monetary value of the issuance:NT$168,000,000\r\nNumber of shares issued:16,800,000 shares\r\n6.If adopting shelf registration, monetary value and number of shares\r\nto be issued this time:Not Applicable.\r\n7.The remaining monetary value and shares after this issuance when\r\nadopting shelf registration:Not Applicable.\r\n8.Par Value per share:NT$10\r\n9.Issue price:NT$60 per share (Supplementary Announcement)\r\n10.Number of shares subscribed for by employees:\r\n15% of the new issued shares,totaling 2,520,000 shares.\r\n11.Ratio of shares subscribed for by existing shareholders:\r\n75% of the new issued shares, totaling 12,600,000 shares, which shall be\r\nsubscribed by the original shareholders according to the shareholding\r\nproportions recorded in the shareholder register on the record date. Per\r\n1000 shares can be subscribed 73.44050144 shares.\r\n12.Method for public sale and no.of shares:\r\n10% of the new issued shares,totaling 1,680,000 shares for public\r\nsubscription.\r\n13.Handling method for fractional shares and shares unsubscripted for by the\r\ndeadline:\r\nIf the new shares distributed to shareholders from this capital\r\nincrease are less than one full share, shareholders may consolidate\r\nthem by handling respective procedures at the Company\u2019s stock\r\ntransfer agent within five days from the book closure date.\r\nFor those shares which original shareholders and employees give up\r\nsubscription or cannot be consolidated within the specified period\r\nor still remain insufficient, and the Chairman shall be authorized\r\nto designate specific persons for purchase of these by cash at issue price.\r\n14.Rights and obligations of these newly issued shares:\r\nThe same as the issued common shares.\r\n15.Utilization of the funds from the current capital increase:\r\nPay off bank loans and enhance working capital.\r\n16.Record date of cash capital increase and share subscription:2026\/01\/14\r\n17.Last date before book closure:2026\/01\/09\r\n18.Book closure starting date:2026\/01\/10\r\n19.Book closure ending date:2026\/01\/14\r\n20.Payment period:2026\/01\/19~2026\/01\/23\r\n21.Date of the agreement with the banks to collect and deposit the proceeds:\r\nIt would be announced after signing the contract.\r\n22.Name of the institution designated to collect the proceeds:\r\nIt would be announced after signing the contract.\r\n23.Name of the bank designated to deposit the proceeds:\r\nIt would be announced after signing the contract.\r\n24.Any other matters that need to be specified:\r\n(1)The plan of cash capital increase has been approved and made effective\r\nby the FSC letter (No.1140367159) dated Dec.22, 2025.\r\n(2)The record date of subscription, record date of capital increase and\r\nother outstanding matters, the chairman has been authorized to handle in\r\naccordance with relevant laws and regulations.\r\n<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

  SEQ_NO \u00a01 Date of announcement 2025\/12\/31 Time of announcement 15:22:21 Subject Announce the record date of 2025 cash capital increase and share subscription schedule (Issue Price) Date of events 2025\/12\/31 To which item it meets paragraph 11 Statement 1.Date of the board of directors resolution or decision by the Company for record date:2025\/12\/22 2.Whether …<\/p>\n

Announce the record date of 2025 cash capital increase and share subscription schedule (Issue Price)<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-10211","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=10211"}],"version-history":[{"count":1,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10211\/revisions"}],"predecessor-version":[{"id":10212,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/10211\/revisions\/10212"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=10211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=10211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=10211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}